Compare SYK & WELL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SYK | WELL |
|---|---|---|
| Founded | 1941 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.2B | 131.1B |
| IPO Year | N/A | N/A |
| Metric | SYK | WELL |
|---|---|---|
| Price | $354.39 | $186.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 10 |
| Target Price | ★ $432.14 | $203.90 |
| AVG Volume (30 Days) | 1.6M | ★ 3.5M |
| Earning Date | 01-27-2026 | 10-27-2025 |
| Dividend Yield | 0.95% | ★ 1.58% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 7.61 | 1.46 |
| Revenue | ★ $24,381,000,000.00 | $9,907,853,000.00 |
| Revenue This Year | $12.01 | $30.93 |
| Revenue Next Year | $8.59 | $17.66 |
| P/E Ratio | ★ $46.52 | $127.98 |
| Revenue Growth | 10.95 | ★ 32.28 |
| 52 Week Low | $329.16 | $123.11 |
| 52 Week High | $406.19 | $209.05 |
| Indicator | SYK | WELL |
|---|---|---|
| Relative Strength Index (RSI) | 40.90 | 38.77 |
| Support Level | $347.26 | $183.60 |
| Resistance Level | $361.00 | $205.55 |
| Average True Range (ATR) | 6.29 | 4.23 |
| MACD | -1.44 | -2.87 |
| Stochastic Oscillator | 24.30 | 12.89 |
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
Welltower owns a diversified healthcare portfolio of 2,391 in-place properties spread across the senior housing, medical office, and skilled nursing/postacute care sectors. The portfolio includes over 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to that of the United States.